SK280190B6 - Ureidové deriváty poly-4-amino-2-karboxy-1-metyl-p - Google Patents

Ureidové deriváty poly-4-amino-2-karboxy-1-metyl-p Download PDF

Info

Publication number
SK280190B6
SK280190B6 SK56-91A SK5691A SK280190B6 SK 280190 B6 SK280190 B6 SK 280190B6 SK 5691 A SK5691 A SK 5691A SK 280190 B6 SK280190 B6 SK 280190B6
Authority
SK
Slovakia
Prior art keywords
methyl
bis
imino
pyrrole
carbonyl
Prior art date
Application number
SK56-91A
Other languages
English (en)
Slovak (sk)
Inventor
Nicola Mongelli
Giovanni Biasoli
Alfredo Paio
Maria Grandi
Marina Ciomei
Original Assignee
Farmitalia Carlo Erba S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba S.R.L. filed Critical Farmitalia Carlo Erba S.R.L.
Publication of SK280190B6 publication Critical patent/SK280190B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyamides (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK56-91A 1990-01-11 1991-01-11 Ureidové deriváty poly-4-amino-2-karboxy-1-metyl-p SK280190B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909000644A GB9000644D0 (en) 1990-01-11 1990-01-11 New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds

Publications (1)

Publication Number Publication Date
SK280190B6 true SK280190B6 (sk) 1999-09-10

Family

ID=10669147

Family Applications (1)

Application Number Title Priority Date Filing Date
SK56-91A SK280190B6 (sk) 1990-01-11 1991-01-11 Ureidové deriváty poly-4-amino-2-karboxy-1-metyl-p

Country Status (33)

Country Link
US (3) US5260329A (bg)
EP (1) EP0462258B1 (bg)
JP (1) JP3121343B2 (bg)
KR (1) KR0176258B1 (bg)
CN (1) CN1032750C (bg)
AT (1) ATE131810T1 (bg)
AU (1) AU647446B2 (bg)
BG (1) BG60534B2 (bg)
CA (1) CA2050331C (bg)
CZ (1) CZ285251B6 (bg)
DE (1) DE69115570T2 (bg)
DK (1) DK0462258T3 (bg)
ES (1) ES2084153T3 (bg)
FI (1) FI99011C (bg)
GB (1) GB9000644D0 (bg)
GR (1) GR3018767T3 (bg)
HK (1) HK1006455A1 (bg)
HR (1) HRP930311B1 (bg)
HU (2) HUT61280A (bg)
IE (1) IE69462B1 (bg)
IL (1) IL96875A (bg)
MX (1) MX9203119A (bg)
MY (1) MY107890A (bg)
NO (1) NO176274C (bg)
NZ (1) NZ236707A (bg)
PT (1) PT96455B (bg)
RU (1) RU2078079C1 (bg)
SI (1) SI9110025B (bg)
SK (1) SK280190B6 (bg)
UA (1) UA32513A (bg)
WO (1) WO1991010649A1 (bg)
YU (1) YU48548B (bg)
ZA (1) ZA91177B (bg)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
CA2103665C (en) * 1991-02-06 2003-04-15 J. William Lown Oligopeptide antiretroviral agents
GB2261661A (en) * 1991-11-21 1993-05-26 Erba Carlo Spa Derivatives of poly-4-amino-2-carboxy-1-methyl pyrroles
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9225475D0 (en) * 1992-12-05 1993-01-27 Imp Cancer Res Tech Compounds to combat angiogenesis
US8143283B1 (en) 1993-03-01 2012-03-27 The Children's Medical Center Corporation Methods for treating blood-born tumors with thalidomide
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US6114355A (en) * 1993-03-01 2000-09-05 D'amato; Robert Methods and compositions for inhibition of angiogenesis
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
DE4320157A1 (de) * 1993-06-18 1994-12-22 Bayer Ag Verwendung von 1,2,4-Dithiazolium-Salzen als Chemotherapeutica
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
GB9403909D0 (en) * 1994-03-01 1994-04-20 Erba Carlo Spa Ureido derivatives of naphthalenephosphonic acids and process for their preparation
GB9504065D0 (en) * 1995-03-01 1995-04-19 Pharmacia Spa Poly-pyrrolecarboxamidonaphthalenic acid derivatives
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
GB2310207A (en) * 1996-02-15 1997-08-20 Pharmacia Spa Antiviral ureido derivatives of substituted heterocyclic compounds
NZ336035A (en) * 1996-11-05 2002-03-28 Childrens Medical Center Angiogenesis inhibitory composition comprising an inhibitory compound and antiinflammatory drug
GB9713732D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Substituted triazinic compounds
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
US6562859B1 (en) 1997-12-04 2003-05-13 The United States Of America As Represented By The Department Of Health And Human Services Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
GB9727524D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Synergistic antitumor composition containing a biologically active ureido compound
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US6232297B1 (en) * 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
WO2002064083A2 (en) 2000-11-30 2002-08-22 The Children's Medical Center Corporation Synthesis of 3-amino-thalidomide and its enantiomers
EP1470119A4 (en) * 2001-06-13 2005-10-19 Genesoft Pharmaceuticals Inc BENZOTHIOPHENE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
WO2003014315A2 (en) * 2001-08-06 2003-02-20 The Children's Medical Center Corporation Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs
NZ556354A (en) * 2001-10-01 2008-10-31 Univ Virginia 2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
KR100836547B1 (ko) * 2002-01-11 2008-06-10 상꾜 가부시키가이샤 아미노 알코올 유도체 또는 포스폰산 유도체 및 이들을함유하는 의약 조성물
WO2005079788A1 (ja) 2004-02-24 2005-09-01 Sankyo Company, Limited アミノアルコール化合物
EP1778712B1 (en) * 2004-08-02 2013-01-30 University Of Virginia Patent Foundation 2-propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
US7576069B2 (en) * 2004-08-02 2009-08-18 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having A2A agonist activity
WO2006023272A1 (en) * 2004-08-02 2006-03-02 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having a2a agonist activity
WO2007120972A2 (en) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785183A (en) * 1954-04-19 1957-03-12 American Cyanamid Co N [4-aminopyrrolyl-2-carbonyl] amino acids
US2785182A (en) * 1954-04-19 1957-03-12 American Cyanamid Co Substituted pyrrolecarboxamidopyroles
CA1308516C (en) * 1987-07-06 1992-10-06 J. William Lown Oligopeptide anticancer and antiviral agents
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha

Also Published As

Publication number Publication date
SI9110025B (sl) 1998-06-30
DE69115570T2 (de) 1996-05-02
KR920701150A (ko) 1992-08-11
KR0176258B1 (ko) 1999-03-20
FI99011B (fi) 1997-06-13
FI914251A0 (fi) 1991-09-09
GR3018767T3 (en) 1996-04-30
HRP930311B1 (en) 2000-04-30
HK1006455A1 (en) 1999-02-26
CN1032750C (zh) 1996-09-11
HUT61280A (en) 1992-12-28
PT96455B (pt) 1998-06-30
CN1053230A (zh) 1991-07-24
SI9110025A (en) 1996-10-31
CA2050331A1 (en) 1991-07-12
ZA91177B (en) 1991-10-30
JP3121343B2 (ja) 2000-12-25
FI99011C (fi) 1997-09-25
AU7059991A (en) 1991-08-05
MY107890A (en) 1996-06-29
IE910074A1 (en) 1991-07-17
RU2078079C1 (ru) 1997-04-27
IL96875A0 (en) 1992-03-29
UA32513A (uk) 2001-02-15
CA2050331C (en) 2002-03-19
US5260329A (en) 1993-11-09
BG60534B2 (bg) 1995-07-28
CS9100056A2 (en) 1991-10-15
HU912923D0 (en) 1992-01-28
ATE131810T1 (de) 1996-01-15
NO176274C (no) 1995-03-08
EP0462258A1 (en) 1991-12-27
JPH04504426A (ja) 1992-08-06
HRP930311A2 (en) 1994-12-31
NO913572L (no) 1991-09-10
DK0462258T3 (da) 1996-01-29
US5420296A (en) 1995-05-30
IL96875A (en) 1995-03-30
YU2591A (sh) 1994-05-10
NO913572D0 (no) 1991-09-10
PT96455A (pt) 1991-10-15
GB9000644D0 (en) 1990-03-14
ES2084153T3 (es) 1996-05-01
AU647446B2 (en) 1994-03-24
DE69115570D1 (de) 1996-02-01
HU211237A9 (en) 1995-11-28
NO176274B (no) 1994-11-28
YU48548B (sh) 1998-11-05
MX9203119A (es) 1992-07-01
NZ236707A (en) 1992-10-28
US5593976A (en) 1997-01-14
IE69462B1 (en) 1996-09-18
CZ285251B6 (cs) 1999-06-16
WO1991010649A1 (en) 1991-07-25
EP0462258B1 (en) 1995-12-20

Similar Documents

Publication Publication Date Title
SK280190B6 (sk) Ureidové deriváty poly-4-amino-2-karboxy-1-metyl-p
AU776053B2 (en) Diazepan derivatives or salts thereof
PL174279B1 (pl) Pochodne kwasu hydroksamowego
DE69630209T2 (de) Bicyclische benzazepin-derivate als vasopressin-antagonisten
DE10235639A1 (de) Neue Prodrugs von 1-Methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amid, ihre Herstellung und ihre Verwendung als Arzneimittel
DE68910523T2 (de) Trizyklische 3-oxo-propannitril-derivate und verfahren zu deren herstellung.
US5534539A (en) Biologically active ureido derivatives useful as anit-metastic agenst
DE69402548T2 (de) Carbocyclische nucleoside mittel nützlich als selektive inhibitoren von proinflammatorischen cytokinen
JPH06184098A (ja) 治療上有効なナフタレンスルホン系ピロールカルボキサミド誘導体
WO1999000364A1 (en) Poly-branched polycarboxamido compounds
JP2019504051A (ja) インドリジン誘導体、組成物、及び使用方法
AU670194B2 (en) Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
AU2003221636B2 (en) Amino acid analogues
CA2092152A1 (en) Phenoxyacetic acid compounds and medical preparations containing them
IL103448A (en) Salts of the base 4-Amidino-1-Indanone-'2-Amidinohidzone, pharmaceutical preparations containing them and their preparation
JPH08109177A (ja) シクロアルキルアルキルアミン誘導体およびその用途